Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 11.11.2019 | EN | Official Journal of the European Union | C 383/35 |

---

Order of the Court (Ninth Chamber) of 5 September 2019 (request for a preliminary ruling from the High Court of Justice (Chancery Division) – United Kingdom) — Eli Lilly and Company v Genentech Inc.

(Case C-239/19) [(1)](#ntr1-C_2019383EN.01003502-E0001)

(Reference for a preliminary ruling - Article 53(2) of the Rules of Procedure of the Court of Justice - Supplementary protection certificate for medicinal products - Regulation (EC) No 469/2009 - Article 3(b) - Conditions for obtaining - Marketing authorisation - Authorisation issued to a third party - Manifest inadmissibility)

(2019/C 383/39)

Language of the case: English

Referring court

High Court of Justice (Chancery Division)

Parties to the main proceedings

Applicant: Eli Lilly and Company

Defendant: Genentech Inc.

Operative part of the order

The request for a preliminary ruling from the High Court of Justice (England & Wales), Chancery Division (Patents Court) (United Kingdom), made by decision of 4 March 2019, is manifestly inadmissible.

---

---

[Top](#document1)